Literature DB >> 32930385

CD56dim CD57- NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+ NKG2C+ memory-like NK cells.

Polina A Kobyzeva1, Maria A Streltsova1, Sofya A Erokhina1, Leonid M Kanevskiy1, William G Telford2, Alexander M Sapozhnikov1, Elena I Kovalenko1.   

Abstract

Formation of the adaptive-like NK cell subset in response to HCMV infection is associated with epigenetic rearrangements, accompanied by multiple changes in the protein expression. This includes a decrease in the expression level of the adapter chain FcεRIγ, NKp30, and NKG2A receptors and an increase in the expression of NKG2C receptor, some KIR family receptors, and co-stimulating molecule CD2. Besides, adaptive-like NK cells are characterized by surface expression of CD57, a marker of highly differentiated cells. Here, it is shown that CD57-negative CD56dim NKG2C+ NK cells may undergo the same changes, as established by the similarity of the phenotypic expression pattern with that of the adaptive-like CD57+ NKG2C+ NK cells. Regardless of their differentiation stage, NKG2C-positive NK cells had increased HLA-DR expression indicating an activated state, both ex vivo and after cultivation in stimulating conditions. Additionally, CD57- NKG2C+ NK cells exhibited better proliferative activity compared to CD57+ NKG2C+ and NKG2C- NK cells, while retaining high level of natural cytotoxicity. Thus, CD57- NKG2C+ NK cells may represent a less differentiated, but readily expanding stage of the adaptive-like CD57+ NKG2C+ NK cells. Moreover, it is shown that NK cells have certain phenotypic plasticity and may both lose NKG2C expression and acquire it de novo during proliferation, induced by IL-2 and K562-mbIL21 feeder cells. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  HCMV; K562-mbIL21; NK cell clone; cell expansion; differentiation; receptor NKG2C

Mesh:

Substances:

Year:  2020        PMID: 32930385      PMCID: PMC8932339          DOI: 10.1002/JLB.1MA0720-654RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   6.011


  52 in total

1.  Cytokine-induced memory-like natural killer cells.

Authors:  Megan A Cooper; Julie M Elliott; Peter A Keyel; Liping Yang; Javier A Carrero; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

Review 2.  Functions of natural killer cells.

Authors:  Eric Vivier; Elena Tomasello; Myriam Baratin; Thierry Walzer; Sophie Ugolini
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 3.  Human Cytokine-Induced Memory-Like Natural Killer Cells.

Authors:  Melissa M Berrien-Elliott; Julia A Wagner; Todd A Fehniger
Journal:  J Innate Immun       Date:  2015-04-30       Impact factor: 7.349

4.  Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.

Authors:  Zeguang Wu; Christian Sinzger; Giada Frascaroli; Johanna Reichel; Carina Bayer; Li Wang; Reinhold Schirmbeck; Thomas Mertens
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

Review 5.  Human natural killer cell development in secondary lymphoid tissues.

Authors:  Aharon G Freud; Jianhua Yu; Michael A Caligiuri
Journal:  Semin Immunol       Date:  2014-03-21       Impact factor: 11.130

6.  Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.

Authors:  Maria A Streltsova; Sofya A Erokhina; Leonid M Kanevskiy; Dean A Lee; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

Review 7.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

8.  CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.

Authors:  Antoni Chan; Deng-Li Hong; Ann Atzberger; Simon Kollnberger; Andrew D Filer; Christopher D Buckley; Andrew McMichael; Tariq Enver; Paul Bowness
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

9.  Epigenetic regulation of NK cell differentiation and effector functions.

Authors:  Frank Cichocki; Jeffrey S Miller; Stephen K Anderson; Yenan T Bryceson
Journal:  Front Immunol       Date:  2013-02-28       Impact factor: 7.561

10.  Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-γ Production, and Lifespan.

Authors:  Maria A Streltsova; Sofya A Erokhina; Leonid M Kanevskiy; Maria V Grechikhina; Polina A Kobyzeva; Dean A Lee; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  Int J Mol Sci       Date:  2019-01-21       Impact factor: 5.923

View more
  3 in total

1.  Pro- and Anti-Inflammatory Cytokines in the Context of NK Cell-Trophoblast Interactions.

Authors:  Valentina Mikhailova; Polina Grebenkina; Evgeniia Khokhlova; Alina Davydova; Zeina Salloum; Elizaveta Tyshchuk; Valeria Zagainova; Kseniia Markova; Igor Kogan; Sergey Selkov; Dmitry Sokolov
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

Review 2.  Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies.

Authors:  Barbara Seliger; Ulrike Koehl
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

3.  Increased Susceptibility of the CD57- NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response.

Authors:  Anastasia I Palamarchuk; Nadezhda A Alekseeva; Maria A Streltsova; Maria O Ustiuzhanina; Polina A Kobyzeva; Sofya A Kust; Maria V Grechikhina; Anna A Boyko; Olga A Shustova; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.